Loading
Medical oncologist who co-chairs the breast disease group at The Christie, the Manchester cancer centre that is a site of the PHOENIX, PARTNER and ASCENT-05 trials for triple-negative disease.
Anne Armstrong is a consultant in medical oncology and honorary senior lecturer at The Christie NHS Foundation Trust in Manchester, where her consultant page lists breast cancer as her specialty and names her co-chair of the trust's Breast Disease Group. The Christie's breast clinical oncology team provides radiotherapy, systemic anti-cancer treatment and specialised surgery for the region, and the trust is a UK site of the PHOENIX window-of-opportunity trial in residual triple-negative disease, of PARTNER and of ASCENT-05. Her name appears as investigator on The Christie's news pages about breast trials.
Shares Breast cancer (all types), Triple-negative breast cancer (TNBC) and the tags breast, uk.
Shares Breast cancer (all types) and the tags breast, uk.
Shares Breast cancer (all types), Triple-negative breast cancer (TNBC) and the tags breast, uk.
Shares Breast cancer (all types) and the tags breast, uk.
Shares Breast cancer (all types) and the tags breast, uk.
Shares Triple-negative breast cancer (TNBC) and the tags breast, uk.
Shares Triple-negative breast cancer (TNBC) and the tags breast, uk.
Shares Triple-negative breast cancer (TNBC) and the tags breast, uk.